The world according to poly(ADP-ribose) polymerase (PARP) - Update 2006

Intensive Care Medicine

Volumn 32, Issue 10, 2006, Pages 1470-1474

  Barth, Eberhard ^a   Radermacher, Peter ^a   Szabó, Csaba ^b,c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOISOQUINOLINONE; INO 1001; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; QUINOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; DNA DAMAGE; DNA MODIFICATION; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; EDITORIAL; ENZYME ACTIVATION; ENZYME INHIBITION; EXCISION REPAIR; FLUORESCENCE MICROSCOPE; HEMORRHAGIC SHOCK; ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY;

ANIMALS; DNA REPAIR; HUMANS; LIVER; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; REPERFUSION INJURY;

EID: 33749263220     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0336-x     Document Type: Editorial

References (27)

1. Virag L, Szabó C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429
2. Mazzon E, Dugo L, De SA, Li JH, Caputi AP, Zhang J, Cuzzocrea S (2002) Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock 17:222-227
3. Di Paola R, Genovese T, Caputi AP, Threadgill M, Thiemermann C, Cuzzocrea S (2004) Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion. Eur J Pharmacol 492:203-210
4. Liaudet L, Szabó A, Soriano FG, Zingarelli B, Szabó C, Salzman AL (2000) Poly(ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 14:134-141
5. Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM, Jing LP (2006) Inhibition of poly(ADP-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass. Shock 25:168-175
6. Kaplan J, O'Connor M, Hake PW, Zingarelli B (2005) Inhibitors of poly(ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration. Shock 23:233-238
7. Kokura S, Wolf RE, Yoshikawa T, Granger DN, Aw TY (1999) Molecular mechanisms of neutrophil-endothelial cell adhesion induced by redox imbalance. Circ Res 84:516-524
8. Szabó G, Soos P, Heger U, Flechtenmacher C, Bahrle S, Zsengeller Z, Szabó C, Hagl S (2005) Poly(ADPribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation. Eur J Cardiothorac Surg 27:226-234
9. Szabó G, Soos P, Bahrle S, Zsengeller Z, Flechtenmacher C, Hagl S, Szabó C (2004) Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass. Eur J Cardiothorac Surg 25:825-832
10. Szabó G, Soos P, Mandera S, Heger U, Flechtenmacher C, Seres L, Zsengeller Z, Sack FU, Szabó C, Hagl S (2004) Mesenteric injury after cardiopulmonary bypass: role of poly(adenosine 5′-diphosphateribose) polymerase. Crit Care Med 32:2392-2397
11. Szabó G, Seres L, Soos P, Flechtenmacher C, Zsengeller Z, Sack FU, Szabó C, Hagl S (2004) Poly-ADP-ribose polymerase inhibition reduces mesenteric injury after cardiopulmonary bypass. Thorac Cardiovasc Surg 52:338-343
12. Liaudet L, Soriano FG, Szabó E, Virag L, Mabley JG, Salzman AL, Szabó C (2000) Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 97:10203-10208
13. Szabó A, Hake P, Salzman AL, Szabó C (1998) 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock. Shock 10:347-353
14. Roesner JP, Vagts DA, Iber T, Eipel C, Vollmar B, Nöldge-Schomburg GFE (2006) Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats. Intensive Care Med DOI10.1007/s00134-006-0335-y
15. Khandoga A, Biberthaler P, Enders G, Krombach F (2004) 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion. Crit Care Med 32:472-477
16. Mariscalco MM (2004) Hepatic microcirculation in ischemia/reperfusion: is there a role for poly(adenosine 5′-diphosphate-ribose) polymerases? Crit Care Med 32:605-607
17. Kiefmann R, Heckel K, Schenkat S, Dorger M, Wesierska-Gadek J, Goetz AE (2004) Platelet-endothelial cell interaction in pulmonary microcirculation: the role of PARS. Thromb Haemost 91:761-770
18. de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 94:7303-7307
19. Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo R, Wang ZQ, Schultz PG, Smulson ME (2000) Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 97:11274-11279
20. Hauser B, Gröger M, Ehrmann U, Albicini M, Bruckner UB, Schelzig H, Venkatesh B, Li H, Szabó C, Speit G, Radermacher P, Kick J (2006) The PARP-1 inhibitor INO-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia/reperfusion. Shock 25:633-640
21. Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, Virag L, Deb A, Szabó E, Ungvari Z, Wolin MS, Groves JT, Szabó C (2003) Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107:896-904
22. Naidu BV, Fraga C, Salzman AL, Szabó C, Verrier ED, Mulligan MS (2003) Critical role of reactive nitrogen species in lung ischemia-reperfusion injury. J Heart Lung Transplant 22:784-793
23. Lancel S, Tissier S, Mordon S, Marechal X, Depontieu F, Scherpereel A, Chopin C, Nevière R (2004) Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol 43:2348-2358
24. Mabley JG, Liaudet L, Pacher P, Southan GJ, Groves JT, Salzman AL, Szabó C (2002) Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol Med 8:581-590
25. Obrosova IG, Mabley JG, Zsengeller Z, Charniauskaya T, Abatan OI, Groves JT, Szabó C (2005) Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J 19:401-403
26. Mabley JG, Horvath EM, Murthy KG, Zsengeller Z, Vaslin A, Benko R, Kollai M, Szabó C (2005) Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J Pharmacol Exp Ther 315:812-820
27. Gero D, Szabó C (2006) Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury. Curr Pharmaceut Design (in press)